STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial–Mesenchymal Transition

Table 2

Results of multivariate analyses of clinicopathological factors affecting overall survival rate after surgery.

Clinicopathological variable	Multivariate analysis
	HR (95% CI)	p value
Gender (male/female)	1.35(0.84-2.05)	0.29
Histology (well/moderate, poor)	1.13(0.95-1.46)	0.08
Tumor size (<3cm/≥3cm)	2.43(1.15-4.63)	0.02
Lymph node metastasis (Yes/No)	2.84(1.33-5.75)	0.01
STC2 mRNA expression (low/high)	3.26(2.34-8.64)	0.006